NDC 60505-3221

Rivastigmine Tartrate

Rivastigmine Tartrate

Rivastigmine Tartrate is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Apotex Corp.. The primary component is Rivastigmine Tartrate.

Product ID60505-3221_35787807-49b2-6034-dcb0-36037574fb42
NDC60505-3221
Product TypeHuman Prescription Drug
Proprietary NameRivastigmine Tartrate
Generic NameRivastigmine Tartrate
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2013-02-20
Marketing CategoryANDA / ANDA
Application NumberANDA091072
Labeler NameApotex Corp.
Substance NameRIVASTIGMINE TARTRATE
Active Ingredient Strength3 mg/1
Pharm ClassesCholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 60505-3221-8

1000 CAPSULE in 1 BOTTLE (60505-3221-8)
Marketing Start Date2013-02-20
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 60505-3221-5 [60505322105]

Rivastigmine Tartrate CAPSULE
Marketing CategoryANDA
Application NumberANDA091072
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-02-20
Marketing End Date2019-04-30

NDC 60505-3221-0 [60505322100]

Rivastigmine Tartrate CAPSULE
Marketing CategoryANDA
Application NumberANDA091072
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-02-20
Marketing End Date2018-08-15

NDC 60505-3221-7 [60505322107]

Rivastigmine Tartrate CAPSULE
Marketing CategoryANDA
Application NumberANDA091072
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-02-20
Marketing End Date2018-08-15

NDC 60505-3221-3 [60505322103]

Rivastigmine Tartrate CAPSULE
Marketing CategoryANDA
Application NumberANDA091072
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-02-20
Marketing End Date2019-04-30

NDC 60505-3221-6 [60505322106]

Rivastigmine Tartrate CAPSULE
Marketing CategoryANDA
Application NumberANDA091072
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2013-02-20
Marketing End Date2019-04-30

NDC 60505-3221-1 [60505322101]

Rivastigmine Tartrate CAPSULE
Marketing CategoryANDA
Application NumberANDA091072
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-02-20
Marketing End Date2019-04-30

NDC 60505-3221-8 [60505322108]

Rivastigmine Tartrate CAPSULE
Marketing CategoryANDA
Application NumberANDA091072
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-02-20
Marketing End Date2019-04-30

Drug Details

Active Ingredients

IngredientStrength
RIVASTIGMINE TARTRATE3 mg/1

OpenFDA Data

SPL SET ID:ca943349-53ea-2b6e-53c3-0265b1a81f8a
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 312835
  • 314214
  • 314215
  • 312836

    • Pharmacological Class

    • Cholinesterase Inhibitor [EPC]
    • Cholinesterase Inhibitors [MoA]

    Medicade Reported Pricing

    60505322106 RIVASTIGMINE 3 MG CAPSULE

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Rivastigmine Tartrate" or generic name "Rivastigmine Tartrate"

    NDCBrand NameGeneric Name
    0591-3208Rivastigmine TartrateRivastigmine Tartrate
    0591-3209Rivastigmine TartrateRivastigmine Tartrate
    0591-3210Rivastigmine TartrateRivastigmine Tartrate
    0591-3211Rivastigmine TartrateRivastigmine Tartrate
    0781-2614Rivastigmine Tartraterivastigmine tartrate
    0781-2615Rivastigmine Tartraterivastigmine tartrate
    0781-2616Rivastigmine Tartraterivastigmine tartrate
    0781-2617Rivastigmine Tartraterivastigmine tartrate
    0904-6587Rivastigmine TartrateRivastigmine Tartrate
    0904-7107Rivastigmine TartrateRivastigmine Tartrate
    27241-090RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATE
    27241-091RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATE
    27241-092RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATE
    27241-093RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATE
    33342-089RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATE
    33342-090RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATE
    33342-091RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATE
    33342-092RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATE
    46708-063Rivastigmine TartrateRivastigmine Tartrate
    46708-064Rivastigmine TartrateRivastigmine Tartrate
    46708-065Rivastigmine TartrateRivastigmine Tartrate
    46708-066Rivastigmine TartrateRivastigmine Tartrate
    68084-550Rivastigmine TartrateRivastigmine Tartrate
    68151-4134Rivastigmine TartrateRivastigmine Tartrate
    71209-012Rivastigmine TartrateRivastigmine Tartrate
    71209-013Rivastigmine TartrateRivastigmine Tartrate
    71209-014Rivastigmine TartrateRivastigmine Tartrate
    71209-015Rivastigmine TartrateRivastigmine Tartrate
    75834-136RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATE
    75834-133RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATE
    75834-134RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATE
    75834-135RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATE
    51991-793Rivastigmine TartrateRivastigmine Tartrate
    51991-794Rivastigmine TartrateRivastigmine Tartrate
    51991-796Rivastigmine TartrateRivastigmine Tartrate
    51991-795Rivastigmine TartrateRivastigmine Tartrate
    55111-354Rivastigmine TartrateRivastigmine Tartrate
    55111-355Rivastigmine TartrateRivastigmine Tartrate
    55111-353Rivastigmine TartrateRivastigmine Tartrate
    55111-352Rivastigmine TartrateRivastigmine Tartrate
    60429-394Rivastigmine TartrateRivastigmine Tartrate
    60429-393Rivastigmine TartrateRivastigmine Tartrate
    60505-3222Rivastigmine TartrateRivastigmine Tartrate
    60505-3221Rivastigmine TartrateRivastigmine Tartrate
    60429-396Rivastigmine TartrateRivastigmine Tartrate
    60429-395Rivastigmine TartrateRivastigmine Tartrate
    60505-3220Rivastigmine TartrateRivastigmine Tartrate
    60505-3223Rivastigmine TartrateRivastigmine Tartrate
    62756-145Rivastigmine TartrateRivastigmine Tartrate
    62756-148Rivastigmine TartrateRivastigmine Tartrate
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.